NCT02507583 2025-05-07
Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma
Thomas Jefferson University
Phase 1 Completed
Thomas Jefferson University
Huashan Hospital
Barretos Cancer Hospital
INSYS Therapeutics Inc
St. Jude Children's Research Hospital